Announced
Completed
Synopsis
Oncomatryx, a biopharmaceutical company, completed the acquisition of Tube Pharmaceuticals, a German a biopharmaceutical firm. Financial terms were not disclosed. "This strategic agreement is a significant milestone for Oncomatryx. It consolidates our technological portfolio and our commitment to target the microenvironment of the most invasive tumors. In addition, bringing Dr. Richter's knowledge and experience into our team will open up even more possibilities in the design and development of novel ADCs," Laureano Simon, Oncomatryx Founder.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Bidder Team (3)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite